Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
23 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/englands-nice-recommends-filspari-sparsentan-as-a-treatment-option-for-iga-nephropathy-302464100.html
29 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/csl-vifor-and-travere-therapeutics-announce-standard-eu-approval-for-filspari-in-iga-nephropathy-302439782.html
11 Dec 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/csl-vifor-floats-ps23m-offer-end-uk-competition-authority-probe-alleged-disinformation
10 Dec 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/csl-vifor-floats-ps23m-offer-end-uk-competition-authority-probe-alleged-disinformation
04 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/04/2973879/0/en/Memo-Therapeutics-AG-Appoints-Frits-van-Alphen-MD-as-Chief-Development-Officer.html
17 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/17/2964752/0/en/Travere-Therapeutics-and-CSL-Vifor-Announce-Swissmedic-Approval-of-FILSPARI-sparsentan-for-the-Treatment-of-IgA-Nephropathy.html
Inspections and registrations
ABOUT THIS PAGE
CSL Vifor is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of Ferric Carboxymaltose bulk with JDMF offered by CSL Vifor
Find a price of Glycopyrronium Bromide bulk with DMF offered by CSL Vifor
Find a price of Iron bulk with JDMF offered by CSL Vifor
Find a price of Iron Sucrose bulk with DMF offered by CSL Vifor
Find a price of Oxoiron bulk with JDMF offered by CSL Vifor
Find a price of Carboxymethylated Dextran bulk offered by CSL Vifor
Find a price of Iron Dextran bulk offered by CSL Vifor